Advertisement
News
Subscribe to MDT Magazine News

Screening tool may better identify heart disease in African-Americans

November 29, 2010 8:40 pm | by EurekAlert | Comments

(Radiological Society of North America) Researchers say they may have an explanation as to why African-Americans, despite having lower amounts of coronary artery calcification, are at increased risk for heart attacks and other cardiovascular events compared with Caucasians.

TOPICS:

People with sleep apnea at higher risk for aggressive heart disease

November 29, 2010 8:36 pm | by EurekAlert | Comments

(Radiological Society of North America) People with obstructive sleep apnea, a sleep disorder associated with obesity, have more non-calcified or "bad" plaque in their coronary arteries, according to a new study.

TOPICS:

Hill-Rom names new Chief Technology Officer(2)

November 29, 2010 2:46 pm | by The Associated Press | Comments

Hill-Rom Holdings Inc., maker of hospital beds and other medical technology, announced Monday that it has named Brian Lawrence senior vice president and chief technology officer.Lawrence succeeds Abel Ang, who will take on a promoted role as regional president of Hill-Rom's Asia/Pacific...

Advertisement

Hill-Rom names new Chief Technology Officer

November 29, 2010 2:45 pm | Comments

Hill-Rom Holdings Inc., maker of hospital beds and other medical technology, announced Monday that it has named Brian Lawrence senior vice president and chief technology officer.Lawrence succeeds Abel Ang, who will take on a promoted role as regional president of Hill-Rom's Asia/Pacific...

McKesson says it took out $2B bridge loan

November 29, 2010 1:45 pm | by The Associated Press | Comments

Medical supplies distributor McKesson Corp. said Monday it took out a $2 billion bridge loan to complete its purchase of US Oncology.McKesson said it will use the one-year loan to pay for the $560 million merger, pay back some of US Oncology's debt, and cover the transaction costs connected...

AMAG avoids FDA 'black box' warning

November 29, 2010 1:35 pm | by Mass High Tech: The Journal of New England Technology | Comments

AMAG Pharmaceuticals Inc. saw its stock jump almost 14 percent Monday, following news that the U.S. Food and Drug Administration will not slap a dreaded “black box” warning label on its drug to treat iron deficiency anemia.

TOPICS:

Calif. regulator fines insurers for underpayment

November 29, 2010 11:45 am | by SHAYA TAYEFE MOHAJER - Associated Press - Associated Press | Comments

California's seven largest health insurers face nearly $5 million in fines for failing to pay hospitals and physicians fairly and on time, following an 18-month audit by a state regulator, an official said Monday.Improper claim payments are burdening health providers as they struggle to stay...

Male reproductive problems may add to falling fertility rates(2)

November 29, 2010 11:40 am | by EurekAlert | Comments

(European Science Foundation) Reduced male fertility may be making it even harder for couples to conceive and be contributing to low birth rates in many countries, reveals a new European Science Foundation report launching today at a meeting in Paris.

TOPICS:
Advertisement

Male reproductive problems may add to falling fertility rates

November 29, 2010 11:39 am | Comments

European Science Foundation

Study shows that blood stem cells are influenced by their offspring

November 29, 2010 10:43 am | by EurekAlert | Comments

(Walter and Eliza Hall Institute) A new study by researchers at the Walter and Eliza Hall Institute in Melbourne, Australia, has shown that mature blood cells can communicate with, and influence the behavior of, their stem cell "parents."

TOPICS:

Screening breast MR diagnoses cancer in women with history of LCIS

November 29, 2010 10:38 am | by Diagnostic Imaging | Comments

Women with a history of biopsy-proven lobular carcinoma in situ (LCIS) appear to benefit from the addition of MRI to mammography for annual breast cancer screening. A retrospective study from Memorial Sloan-Kettering Cancer Institute presented Sunday at the 2010 RSNA meeting indicates the...

TOPICS:

Amarin treatment for high triglycerides shows progress in trials

November 29, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Biopharmaceutical Amarin Corp. plc today is reporting positive, statistically significant top-line results from its first Phase 3 clinical trial of lead drug candidate AMR101, which is being investigated as a treatment for very high triglycerides.

TOPICS:

Prescriptions for teens and young adults on the rise

November 29, 2010 10:35 am | by EurekAlert | Comments

(University of Rochester Medical Center) Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics.

TOPICS:

Joule appoints d'Esparbes, Madden to senior roles

November 29, 2010 8:43 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge biofuels company Joule Unlimited Inc. has appointed Eric d’Esparbes as chief financial officer and Kevin Madden as vice president of biology operations at the firm.

TOPICS:

EMD Serono MD drug review extended

November 29, 2010 8:42 am | by Mass High Tech: The Journal of New England Technology | Comments

EMD Serono's Cladribine Tablets, its drug candidate for treating Multiple Sclerosis, has been given an extension of three months in its FDA review period for treating relapsing MS.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading